More Than Half of People With Rheumatoid Arthritis Have Anemia
THURSDAY, Jan. 2, 2025 -- Anemia is prevalent among patients with rheumatoid arthritis (RA), according to a study published online Oct. 26 in Cureus.
Jamal Shah, M.B.B.S., from Khyber Teaching Hospital in Peshawar, Pakistan, and colleagues examined the prevalence of anemia among 330 patients with RA presenting at a tertiary care hospital in 2023.
The researchers found that more than half of participants had anemia (54.55 percent). The mean hemoglobin level among these patients was 11.41 g/dL, and the red blood cell count averaged 4.26 million/µL. The Disease Activity Score was higher in patients with anemia (mean of 5.23 versus 4.98 in those without anemia). Most people with anemia had elevated C-reactive protein levels (83.33 percent; mean C-reactive protein, 28.79 mg/L) and an elevated erythrocyte sedimentation rate (88.89 percent; mean erythrocyte sedimentation rate, 45.17 mm/hour). There were significant associations observed between anemia and longer disease duration, higher RA severity, and increased inflammatory markers.
"These findings underscore the critical importance of routine screening and management of anemia in RA patients, particularly those with severe or prolonged disease, as addressing anemia could enhance overall patient outcomes and quality of life," the authors write. "Future research should focus on elucidating the mechanisms linking RA and anemia, conducting longitudinal studies to better understand these associations over time, and evaluating the effectiveness of anemia treatments in improving patient health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Digital Intervention Aids Psychological Outcomes With Inflammatory Rheumatic Diseases
WEDNESDAY, Sept. 17, 2025 -- A digital psychological intervention is safe and effective for individuals with inflammatory rheumatic diseases (IRDs), according to a study published...
Methotrexate Cuts Systolic BP in Rheumatoid Arthritis
MONDAY, Sept. 15, 2025 -- For patients with rheumatoid arthritis (RA), methotrexate significantly reduces systolic blood pressure (SBP), according to a study published online July...
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.